Atrial Fibrillation (AFib) Awareness
The Heart Rhythm Society (HRS), through its efforts during Atrial Fibrillation Awareness Month in September and throughout the year, is working to increase public knowledge of AFib, including its symptoms, warning signs, and available treatment options.
Atrial Fibrillation — also known as AFib or AF — is the most common arrhythmia. It affects more than 2.5 million American adults and 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances.
It is characterized by a rapid and irregular heartbeat caused when the top chambers of the heart (the atria) quiver (fibrillate) erratically, sometimes faster than 200 times per minute. The condition can have a significant negative impact on an individual's quality of life, causing heart palpitations, chronic fatigue, debilitating pain and can increase the risk of stroke fivefold.
AFib Awareness Resources
- About Atrial Fibrillation (AFib)
- AF Stroke Survey
- Collaborative Resources
- Patient Resources
- Promotional Items
- Promotional Videos
- Provider Resources
What is Electrophysiology?
Electrophysiology is a subspecialty branch of cardiology. An electrophysiologist (EP) is highly trained in the management of electrical properties of the heart, and is the most knowledgeable doctor to deal with the many often complex options for treating heart beat, or heart rhythm, disorders. If you or your doctor feels that you are experiencing a problem related to an abnormal heart beat, seeing an EP may provide you with the best chance of having this problem properly diagnosed and may offer the best options for treatment.
The AFib Risk Assessment is an interactive tool designed to help individuals estimate their risk of atrial fibrillation (AFib). Many individuals living with AFibhave no symptoms and are unaware of their condition until they are suffering from complications, which may require emergency treatment.
Learn your risk by using this online tool! It’s fast and easy — simply answer a few questions regarding your health and get your results. After you have finished using the AFib Risk Assessment, please consult with your physician regarding your results.
The Atrial Fibrillation Disease State Initiative is supported in part by Boehringer Ingelheim, Janssen, Medtronic, and Bristol-Myers Squibb.